TuHURA Biosciences Announces its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual Milestone [Yahoo! Finance]
TuHURA Biosciences Announces its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual Milestone
TuHURA Biosciences (NASDAQ:HURA) was downgraded by analysts at
Wall Stre
TuHURA Biosciences Provides Corporate Update Following Recent Financing [Yahoo! Finance]
TuHURA Biosciences Provides Corporate Update Following Recent Financing